|
FAR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.655500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.636010E-01 |
| Normal-vs-Stage2 |
1.874000E-01 |
| Normal-vs-Stage3 |
9.857400E-01 |
| Normal-vs-Stage4 |
2.854600E-01 |
| Stage1-vs-Stage2 |
4.142800E-01 |
| Stage1-vs-Stage3 |
4.329400E-01 |
| Stage1-vs-Stage4 |
2.488400E-01 |
| Stage2-vs-Stage3 |
2.535800E-01 |
| Stage2-vs-Stage4 |
1.541960E-01 |
| Stage3-vs-Stage4 |
5.579000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.394780E-01 |
| Normal-vs-AfricanAmerican |
1.532380E-01 |
| Normal-vs-Asian |
5.391600E-01 |
| Caucasian-vs-AfricanAmerican |
6.675400E-01 |
| Caucasian-vs-Asian |
7.520200E-01 |
| AfricanAmerican-vs-Asian |
8.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.218000E-01 |
| Normal-vs-Female |
9.435800E-03 |
| Male-vs-Female |
5.433900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.363200E-01 |
| Normal-vs-Extreme_Weight |
3.965200E-01 |
| Normal-vs-Obese |
2.795400E-01 |
| Normal-vs-Extreme_Obese |
8.834200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.845400E-01 |
| Normal_Weight-vs-Obese |
7.846400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.884000E-01 |
| Extreme_Weight-vs-Obese |
7.424200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.283600E-01 |
| Obese-vs-Extreme_Obese |
5.452400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.007380E-01 |
| Normal-vs-Age(41-60Yrs) |
8.855600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.747400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.090600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.398800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.082430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.651700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.715700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.638100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.764420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.297000E-03 |
| Normal-VS-Type2 PRCC |
5.436500E-02 |
| Normal-VS-KIRP CIMP |
6.511800E-01 |
| Normal-VS-Unclassified PRCC |
4.825500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.68029999999542E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.016400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.057800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.523640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.039700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.580400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.212200E-01 |
| Normal-vs-N1 |
9.575400E-01 |
| Normal-vs-N2 |
9.631800E-02 |
| N0-vs-N1 |
5.514400E-01 |
| N0-vs-N2 |
4.031600E-01 |
| N1-vs-N2 |
3.389000E-01 |
|
|
